KLRC1 and cancer: Whether NKG2A and NKG2D, which likely have opposing functions with respect to T cell activation, are both concurrently functional is complex, given that the ligands of these receptors (i.e., HLA-E, and MICA/B, ULBP1-6, respectively) can be inducibly expressed in healthy and cancer tissue.72